Jaguar Health, Inc. (JAGX)
USD 0.86
(-8.51%)
USD 0.86
(-8.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.24 Million | -33.1 Million | -34.97 Million | -15.27 Million | -20.45 Million | -22.73 Million |
| Net Income | -41.3 Million | -49.07 Million | -52.6 Million | -33.8 Million | -38.53 Million | -32.14 Million |
| Depreciation & Amortization | 15.59 Million | 2.29 Million | 1.81 Million | 2.28 Million | 1.92 Million | 1.31 Million |
| Deferred income taxes | 3.1 Million | - | 4.38 Million | 10.32 Million | 7.93 Million | 5.74 Million |
| Stock-based compensation | 2.28 Million | 3.31 Million | 3.97 Million | 2.82 Million | 2.98 Million | 2.02 Million |
| Change in working capital | -10.24 Million | -4.42 Million | 2.26 Million | -3.46 Million | -661.77 Thousand | -925.09 Thousand |
| Other non-cash items | 425 Thousand | 14.78 Million | 5.18 Million | 6.57 Million | 5.89 Million | 1.24 Million |
| Investing Cash Flow | 1.23 Million | -1.67 Million | -6000.00 | -7000.00 | - | -6527.00 |
| Investments in PPE | - | -1.67 Million | -6000.00 | -7000.00 | - | -6527.00 |
| Acquisitions | 1.23 Million | - | 247 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -1.59 Million | -247 Thousand | -7000.00 | - | -6.52 Billion |
| Financing Cash Flow | 34.22 Million | 23.18 Million | 43.93 Million | 19.49 Million | 21.77 Million | 24.54 Million |
| Debt repayment | -100 Thousand | -100 Thousand | -1.92 Million | -1.08 Million | -5.15 Million | -2.25 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | 33 Thousand | - | -30.00 |
| Common Stock Issuance | 32.71 Million | 20.46 Million | 33.57 Million | 1.94 Million | 6.62 Million | 16.68 Million |
| Other Financing Activities | 34.32 Million | 2.81 Million | 12.28 Million | 18.63 Million | 20.29 Million | 22.35 Million |
| Accounts receivables | -88 Thousand | -170 Thousand | 2.82 Million | -2.84 Million | -696.02 Thousand | -528.02 Thousand |
| Accounts payables | -855 Thousand | 902 Thousand | 158 Thousand | -743 Thousand | -62.72 Thousand | -1.94 Million |
| Inventory | -2.16 Million | -2.12 Million | -2.11 Million | -653 Thousand | 1.21 Million | -1.26 Million |
| Other working capital | -7.99 Million | -3.03 Million | 1.4 Million | 769 Thousand | -1.11 Million | 2.81 Million |
| Cash at beginning of period | 5.46 Million | 17.05 Million | 8.09 Million | 3.88 Million | 2.56 Million | 759.86 Thousand |
| Cash at end of period | 6.46 Million | 5.46 Million | 17.05 Million | 8.09 Million | 3.88 Million | 2.56 Million |
| Capital Expenditure | - | -1.67 Million | -6000.00 | -7000.00 | - | -6527.00 |
| Effect of forex changes on cash | 15 Thousand | 16 Thousand | - | - | - | - |
| Net cash flow / Change in cash | 1 Million | -11.58 Million | 8.96 Million | 4.2 Million | 1.31 Million | 1.8 Million |
| Free Cash Flow | -33.24 Million | -34.77 Million | -34.97 Million | -15.28 Million | -20.45 Million | -22.73 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.49 Million | -9.22 Million | -9.17 Million | -41.3 Million | -7.98 Million | -12.1 Million |
| Depreciation & Amortization | 559 Thousand | 610 Thousand | 591 Thousand | 2.38 Million | 625 Thousand | 621 Thousand |
| Deferred income taxes | - | - | 680 Thousand | 3.1 Million | -1.44 Million | 768 Thousand |
| Stock-based compensation | 383 Thousand | 581 Thousand | 582 Thousand | 2.28 Million | 528 Thousand | 527 Thousand |
| Change in working capital | -1.24 Million | -153 Thousand | -3.32 Million | -11.09 Million | -5.59 Million | -1.99 Million |
| Other non-cash items | 2.52 Million | 3.96 Million | 6.95 Million | 24.26 Million | 7.08 Million | 3.13 Million |
| Investing Cash Flow | -16 Thousand | - | 6000.00 | 1.23 Million | -20 Thousand | 6.27 Million |
| Investments in PPE | 8.17 Million | - | - | - | - | - |
| Acquisitions | - | - | 6000.00 | 1.23 Million | -20 Thousand | 15 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -16 Thousand | - | -6.25 Million | - | - | 6.25 Million |
| Financing Cash Flow | 12.57 Million | 12.26 Million | 10.64 Million | 32.99 Million | 1.4 Million | 3.35 Million |
| Debt repayment | -94 Thousand | -222 Thousand | -610 Thousand | -953 Thousand | -293 Thousand | -236 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.66 Million | 12.49 Million | 10.01 Million | 32.71 Million | 1.42 Million | 1.55 Million |
| Other Financing Activities | 12.57 Million | 12.26 Million | 1.23 Million | 1.23 Million | -20 Thousand | 2.04 Million |
| Accounts receivables | 349 Thousand | 465 Thousand | -324 Thousand | 298 Thousand | -277 Thousand | -410 Thousand |
| Accounts payables | 785 Thousand | -1.66 Million | -185 Thousand | -855 Thousand | 490 Thousand | -1.02 Million |
| Inventory | -536 Thousand | 169 Thousand | -810 Thousand | -2.16 Million | -115 Thousand | 420 Thousand |
| Other working capital | -1.83 Million | 873 Thousand | -2 Million | -8.37 Million | -5.69 Million | -981 Thousand |
| Cash at beginning of period | 11.67 Million | 6.46 Million | 3.22 Million | 5.46 Million | 8.62 Million | 14.36 Million |
| Cash at end of period | 16.04 Million | 11.67 Million | 6.46 Million | 6.46 Million | 3.22 Million | 8.62 Million |
| Capital Expenditure | 8.17 Million | - | - | - | - | - |
| Effect of forex changes on cash | -10 Thousand | -19 Thousand | 44 Thousand | 15 Thousand | -20 Thousand | -41 Thousand |
| Net cash flow / Change in cash | 4.37 Million | 5.2 Million | 3.24 Million | 1 Million | -5.4 Million | -5.74 Million |
| Free Cash Flow | - | -7.04 Million | -7.45 Million | -33.24 Million | -6.79 Million | -9.05 Million |
0332
1165
ALNT
IIPR
6183
WPDPF